Skip to search formSkip to main contentSkip to account menu

Plasminogen Activator Inhibitor 2

Known as: Serpin B2, PAI-2, Type 2 Plasminogen Activator Inhibitor 
Member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.
National Institutes of Health

Related topics

Related topics

18 relations
In BloodPlasminogen Activator Inhibitor 1Plasminogen activator inhibitor 2 Ag:ACnc:Pt:PPP:Qn:IAProcess of secretion

Narrower (1)

Plasminogen Activator Inhibitor 2, human

Broader (2)

Plasminogen InactivatorsSerine Proteinase Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6J mice
Abstract To assess the significance of the non-genomic signaling of TCDD (=dioxin) on liver of C57BL/6 mice and HepG2 human… 
2007
2007
Plasminogen activator system in oral squamous cell carcinoma.
2007
2007
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma
Tumor-associated urokinase plasminogen activator (uPA) is a critical marker of invasion and metastasis, has strong prognostic… 
2005
2005
Effects of Seprafilm on peritoneal fibrinolytic system
Background:  There is a high incidence of adhesions after ventral hernia repair with polypropylene mesh. The purpose of the… 
2002
2002
Gonadotrophin surge-induced upregulation of mRNA for plasminogen activator inhibitors 1 and 2 within bovine periovulatory follicular and luteal tissue.
The serine proteinases, tissue-type (tPA) and urokinase (uPA) plasminogen activator, are implicated in the ovulatory processes… 
Highly Cited
1999
Highly Cited
1999
Dissemination risk index based on plasminogen activator system components in primary breast cancer.
PURPOSE To study interactions between disease-free survival (DFS) and four components of the plasminogen activator system… 
1996
1996
Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo.
Many lines of evidence support an involvement of urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in the… 
Highly Cited
1993
Highly Cited
1993
Thrombin Stimulates Expression of Tissue-Type Plasminogen Activator and Plasminogen Activator lnhibitor Type 1 in Cultured Human Vascular Smooth Muscle Cells
Summary The effect of thrombin on the fibrinolytic potential of human vascular smooth muscle cells (SMC) in culture was studied… 
Highly Cited
1989
Highly Cited
1989
Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
In the course of some pathological and experimental nephropathies, intraglomerular fibrin deposits develop, possibly as a… 
1989
1989
Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)